The toxicity of aluminum in plant and animal cell biology is well established, although poorly understood. Several recent studies have identified aluminum as a potential, although highly controversial, contributory factor in the pathology of Alzheimer disease, amyotrophic lateral sclerosis, and dialysis dementia. For example, aluminum has been found in high concentrations in senile plaques and neurofibrillary tangles, which occur in the brains of subjects with Alzheimer disease. However, a mechanism for the entry of aluminum (Al3+) into the cells of the central nervous system (CNS) has yet to be found. Here we describe a possible route of entry for aluminum into the cells of the CNS via the same high-affmnity receptor-ligand system that has been postulated for iron (Fe3 ) delivery to neurons and glial cells. These results suggest that aluminum is able to gain access to the central nervous system under normal physiological conditions. Furthermore, these data suggest that the interaction between transferrin and its receptor may function as a general metal ion regulatory system in the CNS, extending beyond its postulated role in iron regulation.
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The major aluminum (Al3") binding fraction of plasma has been shown to be transferrin (T), the chief iron transport protein in vertebrates (1, 2) . Tf has recently been shown to specifically bind Al3+ ions with a high affinity, approaching its affinity for iron (Fe3+) (3) (4) (5) . Tf also specifically'binds a variety of other metal ions, such as gallium, indium, manganese, and zinc ' (6) (7) (8) . Accordingly, we first investigated the binding kinetics for transferrin-iron (Tf-Fe3+) in the central nervous system (CNS) to examine how cells in the brain may accumulate iron and regulate its content. Second, we examined the relationship between Tf-Fe3+ and Tf-AI3+ regulation in the brain at the level of the Tf receptor (TfR). Tf-Fe3+ normally enters tissues throughout the body by receptormediated endocytosis of the TfR-(Tf)2 complex (1, 2, 9, 10). Tf receptors have been identified on the endothelial cells of brain vasculature (11) (12) (13) and a bidirectional transport of iron and Tf into and out of the brain has also been demonstrated (14) . Histochemical, immunohistochemical, and autoradiographic studies have outlined a differential distribution of iron, Tf, and its receptor throughout the CNS (15) (16) (17) (18) .
Initially in this study, we characterize the CNS TfR of the adult rat by using 1251I-labeled Tf-Fe3+ (125I-Tf-Fe3+). Fur- thermore, Al3+ has been demonstrated to complex to specific binding sites on human Tf at physiological pH, and this association is ligand concentration dependent and reversible (3, 4, 19) . We have extended these results to include rat Tf (see Fig. 1 (18) , and neuroblastoma cell lines (19) . However, this study examined the kinetics of the brain TfR, which is found on membranes of a mixed CNS cell population. All binding experiments were performed with iodinated rat Tf on the rat tissue, in contrast to previous studies in which only human Tf was used in their binding experiments. Our initial competition experiments indicated that there may be a slight species difference between the interaction of rat and human Tf with this TfR.
MATERIALS AND METHODS
Ion Loading of Tf. Rat ApoTf (Sigma) is first rendered ion-free by reconstitution in an EDTA buffer at pH 5.0, dialysis for 6-8 hr in a Centricon-10 microconcentrator, and washing and resuspension in a 0.1 M Tris'HCl/10 mM NaHCO3/100 mM NaCl buffer, pH 7.2. All plasticware used was first washed in EDTA buffer to minimize the exposure to environmental ions that could contaminate the preparation. In the loading procedure, AIKSO4 was used as the source of Al3+ ions and FeNH3 citrate was used as the source for Fe3+ ions. Ion loading, using a 5-fold molar excess of metal ion, was performed in a stepwise (pH 5-7.4) fashion. Unbound metal ions were then removed by dialysis against citric phosphate buffer. The Tf-Fe3+ and Tf-A13+ complexes were iodinated by using a modified chloramine-T procedure (20) and remonitored spectrophotometrically to confirm that no dissociation of ions had occurred as a result of iodination of the Tf-metal complex (as tyrosine residues are involved in the active binding of ions to Tf). Fig. 1 RESULTS AND DISCUSSION The saturation data for Tf-Fe3+ (n = 10 animals; means of all data) indicate that the TfR of the adult rat brain has a Kd of 5.7 nM and a Bmax of 59 fmol per mg of membrane protein when 125I-Tf-Fe3+ was used as a ligand (Fig. 2a) . Saturation experiments with Tf-AI3+ (n = 8 animals; means of all data) indicate that the Kd of the TfR increases to 13.1 nM with a Bmax of 49 fmol per mg of membrane protein when 125i-TfAl3+ was used as a ligand (Fig. 2b) .
The relatively lower affinity of Tf-AI3+ (compared to Tf-Fe3+) for the Tf receptor is still, however, higher than the affinity of Tf-Fe3+ for the receptor in a wide range of other tissues (e.g., hepatocytes, Kd 80 nM; myotubes, Kd 37 nM; lymphocytes, Kd 15 nM) (2, 10). The affinities for Tf-AI3+ and Tf-Fe3+ are lower but within the range of those reported earlier for the brain TfR (1.0 nM) (15) . These different affinities probably reflect a difference in technical approach (including the use of rat instead of human Tf) but are in agreement that the brain TfR has a very high affinity for both Tf-Fe3+ and Tf-Al3+. Because of reports (8) that some Tf complexes-e.g., gallium-Tf (Ga-Tf)-could disrupt normal iron regulatory processes by binding in a relatively nondisplaceable manner with the TfR, we chose to examine whether this could also be the case for Tf-AI3+. This approach would enable us to determine true equilibrium kinetics between the two ligands (Tf-AI3+ and Tf-Fe3+) and the brain TfR. The first part of this study demonstrated a differential affinity of the brain TfR for Tf-Fe3+ and Tf-AI3+; the second part was to determine that these ligands were, indeed, interacting with the same receptor. A series of displacement experiments were performed, and a time course was plotted for the dissociation of the labeled Tf-Fe3+ or Tf-AI3+ from the receptor (Fig. 3) . Collectively, these results demonstrate that cells in the brain possess a specific high-affinity receptor for Tf that is independent of the metal being transported. This Tf-TfR system is postulated to be the route whereby the brain can access iron from the general circulation to meet its high metabolic requirements. However, it is generally accepted that only 30% of the ion binding sites that plasma Tf has available in the circulation are saturated with iron at any time (4) , leaving the remaining 70% available to other ions. Analysis of batches of commercially available "iron saturated" Tf by this laboratory and others has also demonstrated that up to 30%o of these binding sites are actually occupied by Al3' (3) . The results presented in this paper demonstrate that a metal ion other than iron is capable not only of binding to Tf but also of utilizing this interaction to gain access to cells in the brain via the Tf-TfR system. Although our work demonstrates a normal physiological path for Al3+ entry into the brain, it does not directly address the controversial role of Al3+ in neurodegenerative disorders (22) (23) (24) . However, it does suggest that Al3+ may be capable of interfering with normal cellular iron homeostasis and could disrupt irondependent cellular processes (e.g., oxidative phosphorylation) in the CNS. In this regard, it is interesting to note that the chief iron storage protein, ferritin, when isolated from the brains of Alzheimer disease subjects, has a 6-fold higher Al3+ content than normal age-matched controls (25) . This latter observation further suggests that aluminum is accessing the same cellular regulatory routes as iron. Recent studies on the 67Ga binding activity of the plasma Tf obtained from Alzheimer and Down syndrome patients have also suggested that altered Tf-ion binding activity may play a role in differential metal ion access to the brains of these patients (26) .
CONCLUSION
In conclusion, because of the number of recent studies noting the relatively high affinity of Tf for a variety of metal ions, it would appear that Tf may have been defined as an iron transporter protein mainly because of the relatively high abundance of iron in the circulation in relation to these other ions. If this balance were to change because of some environmental, nutritional, or disease factor, Tf could transport these other metal ions and deposit them intracellularly instead of or in addition to iron. Because CNS neurons (in which Al3' accumulation is most marked) are terminally differentiated, the Al3+ transported into these cells will accumulate unless specific systems are available to remove them. Other tissues that access circulatory Tf have a set turnover rate, and metal ion accumulation over time will not be so pronounced. The results of this study thus provide the baseline data for a Tf-specific, but not an iron-specific, system by which metal ion regulatory processes in the normal brain may be examined. A major criticism of the aluminum hypothesis in neurodegenerative disorders, regarding the relative inaccessibility of aluminum to the brain, is now seriously questioned.
